US Stocks
/
Spyre Therapeutics, Inc. Share Price
Spyre Therapeutics, Inc. Share Price

Spyre Therapeutics, Inc. Share Price

NASDAQ: SYRE | Micro Cap
$79.80
-$1.09 (-1.35%) Last updated on 09 Oct, 2026 | 00:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Spyre Therapeutics, Inc. Stock Performance

Open
$78.99
Prev. Close
$80.89
Circuit Range
N/A
Day Range
$77.12 - $80.70
Year Range
$16.22 - $110.14
Volume
1,12,590
Average Traded
$79.23

Spyre Therapeutics, Inc. Share Price Today

As of 9 October 2026, Spyre Therapeutics, Inc.'s share price is $79.80. The stock opened at $78.99, compared to its previous close of $80.89. During today's trading session, Spyre Therapeutics, Inc.'s share price traded between $77.12 and $80.70, with an average price of $78.91. Over the past 52 weeks, the stock has recorded a high of $110.14 and a low of $16.22. In terms of performance, Spyre Therapeutics, Inc.'s share price has risen by 7.08% over the last six months and is up 226.09% on a year-on-year basis.

Spyre Therapeutics, Inc. Share Price Chart

$77.12$80.70
L
Show Current Price
H

Spyre Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$27.61M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.68
Revenue (TTM)
$0.00
Return On Equity (TTM)
-13.62%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-242.79%

Spyre Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.02-$51.83-$58.25-$30.92
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-474.61%-12.39%46.92%

Spyre Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.89$0.00$0.00
Net Profit-$94.88-$149.56-$126.54
Net Profit Margin-10660.67%N/AN/A
Income ChangeN/A-57.63%15.39%

About Spyre Therapeutics, Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Spyre Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$89.77
$79.79
-10.55%
Sep 2026
$88.17
$89.20
-4.69%
Aug 2026
$94.57
$93.59
-4.75%
Jul 2026
$87.58
$98.26
+10.73%
Jun 2026
$73.05
$88.74
+20.75%
May 2026
$74.54
$73.49
-1.38%
Apr 2026
$50.28
$74.52
+47.68%
Mar 2026
$42.41
$50.46
+17.35%
Feb 2026
$31.50
$43.00
+34.50%
Jan 2026
$32.52
$31.97
-2.40%
Dec 2025
$30.24
$32.76
+9.17%
Nov 2025
$23.99
$30.00
+22.62%

SYRE Share Price FAQs

What is Spyre Therapeutics, Inc. share price today?

chevron-up
Spyre Therapeutics, Inc. share price today is $79.80 as on October 9, 2026 at 12:27 am IST.

What is the 52 week high and 52 week low of Spyre Therapeutics, Inc. stock?

chevron-up
The 52 week high of Spyre Therapeutics, Inc. stock is $110.14, while the 52 week low is $16.22 as of 9 Oct '26.

What is SYRE's market capitalisation today?

chevron-up
SYRE market capitalisation is $27.61M as of October 9, 2026, at 12:28 am IST.

What is SYRE's net income for the last quarter?

chevron-up
SYRE's net income for the last quarter is -30.92B USD.

What is the 5 year returns of SYRE?

chevron-up
The 5 year returns of SYRE is -56.40% as on 9 Oct '26.

What is the high & low stock price of SYRE today?

chevron-up
SYRE stock price hit a high of $80.70 and low of $77.12 as of 9 Oct '26.

Can I buy SYRE shares in India?

chevron-up
Yes. You can buy SYRE in India by opening an international trading account.